Fabrication of a drug delivery system that enhances antifungal drug corneal penetration

References

• Ahn M, Yoon KC, Ryu SK, et al. (2011). Clinical aspects and prognosis of mixed microbial (bacterial and fungal) keratitis. Cornea 30:409–13.
   PubMed Web of Science ®Google Scholar
• Alamdarnejad G, Sharif A, Taranejoo S, et al. (2013). Synthesis and characterization of thiolated carboxymethyl chitosan-graft-cyclodextrin nanoparticles as a drug delivery vehicle for albendazole. J Mater Sci Mater Med 24:1939–49.
   PubMed Web of Science ®Google Scholar
• Ali J, Fazil M, Qumbar M, et al. (2016). Colloidal drug delivery system: amplify the ocular delivery. Drug Deliv 23:700–16.
   Web of Science ®Google Scholar
• Alvarado HL, Abrego G, Garduño-Ramirez ML, et al. (2015). Design and optimization of oleanolic/ursolic acid-loaded nanoplatforms for ocular anti-inflammatory applications. Nanomedicine 11:521–30.
   PubMed Web of Science ®Google Scholar
• Baba K, Tanaka Y, Kubota A, et al. (2011). A method for enhancing the ocular penetration of eye drops using nanoparticles of hydrolyzable dye. J Control Release 153:278–87.
   PubMed Web of Science ®Google Scholar
• Bhatta RS, Chandasana H, Chhonker YS, et al. (2012). Mucoadhesive nanoparticles for prolonged ocular delivery of natamycin: in vitro and pharmacokinetics studies. Int J Pharmaceut 432:105–12.
   PubMed Web of Science ®Google Scholar
• Crini G. (2014). Review: a history of cyclodextrins. Chem Rev 114:10940–75.
   PubMed Web of Science ®Google Scholar
• Diebold Y, Calonge M. (2010). Applications of nanoparticles in ophthalmology. Prog Retin Eye Res 29:596–609.
   PubMed Web of Science ®Google Scholar
• Faucci MT, Melani F, Mura P. (2000). 1H-NMR and molecular modelling techniques for the investigation of the inclusion complex of econazole with α-cyclodextrin in the presence of malic acid. J Pharmaceut Biomed Anal 23:25–31.
   PubMed Web of Science ®Google Scholar
• Gan L, Wang J, Jiang M, et al. (2013). Recent advances in topical ophthalmic drug delivery with lipid-based nanocarriers. Drug Discov Today 18:290–7.
   PubMed Web of Science ®Google Scholar
• Ganegoda N, Rao SK. (2004). Antifungal therapy for keratomycoses. Expert Opin Pharmacother 5:865–74.
   PubMed Web of Science ®Google Scholar
• Hermawan D, Wan Ibrahim WA, Sanagi MM, Aboul-Enein HY. (2010). Chiral separation of econazole using micellar electrokinetic chromatography with hydroxypropyl-γ-cyclodextrin. J Pharmaceut Biomed Anal 53:1244–9.
   PubMed Web of Science ®Google Scholar
• Huang JF, Zhong J, Chen G-P, et al. (2016). A hydrogel-based hybrid theranostic contact lens for fungal keratitis. ACS Nano 10:6464–73.
   PubMed Web of Science ®Google Scholar
• Jain D, Carvalho E, Banerjee R. (2010). Biodegradable hybrid polymeric membranes for ocular drug delivery. Acta Biomaterialia 6:1370–9.
   PubMed Web of Science ®Google Scholar
• Kambhampati SP, Kannan RM. (2013). Dendrimer nanoparticles for ocular drug delivery. J Ocul Pharmacol Ther 29:151–65.
   PubMed Web of Science ®Google Scholar
• Kaur IP, Kakkar S. (2010). Topical delivery of antifungal agents. Expert Opin Drug Deliv 7:1303–27.
   PubMed Web of Science ®Google Scholar
• Li JG, Cheng D, Yin T, et al. (2014b). Copolymer of poly(ethylene glycol) and poly(L-lysine) grafting polyethylenimine through a reducible disulfide linkage for siRNA delivery. Nanoscale 6:1732–40.
   PubMed Web of Science ®Google Scholar
• Li, JG, Li Z, Zhou T, et al. (2015). Positively charged micelles based on a triblock copolymer demonstrate enhanced corneal penetration. Int J Nanomed 10:6027–37.
   PubMed Web of Science ®Google Scholar
• Li ZR, Li J, Zhu L, et al. (2016). Celastrol nanomicelles attenuate cytokine secretion in macrophages and inhibit macrophage-induced corneal neovascularization in rats. Int J Nanomed 11:6135–48.
   PubMed Web of Science ®Google Scholar
• Liu LH, Wu H, Riduan SN, et al. (2013). Short imidazolium chains effectively clear fungal biofilm in keratitis treatment. Biomaterials 34:1018–23.
   PubMed Web of Science ®Google Scholar
• Li JG, Yu X, Wang Y, et al. (2014a). A reduction and pH dual-sensitive polymeric vector for long-circulating and tumor-targeted siRNA delivery. Adv Mater 26:8217–24.
   PubMed Web of Science ®Google Scholar
• Loftssona T, Järvinen T. (1999). Cyclodextrins in ophthalmic drug delivery. Adv Drug Deliv Rev 36:59–79.
   PubMed Web of Science ®Google Scholar
• Mannermaa E, Vellonen KS, Urtti A. (2006). Drug transport in corneal epithelium and blood-retina barrier: emerging role of transporters in ocular pharmacokinetics. Adv Drug Deliv Rev 58:1136–63.
   PubMed Web of Science ®Google Scholar
• Mura P, Faucci MT, Manderioli A, Bramanti G. (1999). Influence of the preparation method on the physicochemical properties of binary systems of econazole with cyclodextrins. Int J Pharmaceut 193:85–95.
   PubMed Web of Science ®Google Scholar
• Mura P, Faucci MT, Manderioli A, Bramanti G. (2001). Of econazole with hydroxyacids and cyclodextrins. J Incl Phenom Macrocycl Chem 39:131–8.
   Web of Science ®Google Scholar
• Oji EO, Clayton YM. (1982). The role of econazole in the management of oculomycosis. Int Ophthalmol 4:137–42.
   PubMed Web of Science ®Google Scholar
• Pedersen M, Bjerregaard S, Jacobsen J, Sørensen AM. (1998). An econazole β-cyclodextrin inclusion complex: an unusual dissolution rate, supersaturation, and biological efficacy example. Intl J Pharmaceut 165:57–68.
   Web of Science ®Google Scholar
• Prabaharan M, Jayakumar R. (2009). Chitosan-graft-β-cyclodextrin scaffolds with controlled drug release capability for tissue engineering applications. Int J Biologic Macromol 44:320–5.
   PubMed Web of Science ®Google Scholar
• Prabaharan M, Mano JF. (2005). Hydroxypropyl chitosan bearing beta-cyclodextrin cavities: synthesis and slow release of its inclusion complex with a model hydrophobic drug. Macromol Biosci 5:965–73.
   PubMed Web of Science ®Google Scholar
• Sanna V, Gavini E, Cossu M, et al. (2007). Solid lipid nanoparticles (SLN) as carriers for the topical delivery of econazole nitrate: in-vitro characterization, ex-vivo and in-vivo studies. J Pharma Pharmacol 59:1057–64.
   Web of Science ®Google Scholar
• Sigurdsson HH, Stefánsson E, Gudmundsdóttir E, et al. (2005). Cyclodextrin formulation of dorzolamide and its distribution in the eye after topical administration. J Control Release 102:255–62.
   PubMed Web of Science ®Google Scholar
• Sosnik A, das Neves J, Sarmento B. (2014). Mucoadhesive polymers in the design of nano-drug delivery systems for administration by non-parenteral routes: a review. Prog Polym Sci 39:2030–75.
   Web of Science ®Google Scholar
• Urtti A. (2006). Challenges and obstacles of ocular pharmacokinetics and drug delivery. Adv Drug Deliv Rev 58:1131–5.
   PubMed Web of Science ®Google Scholar
• Wilhelmus KR. (2001). The Draize eye test. Surv Ophthalmol 45:493–515.
   PubMed Web of Science ®Google Scholar
• Wu H, Ong ZY, Liu S, et al. (2015). Synthetic β-sheet forming peptide amphiphiles for treatment of fungal keratitis. Biomaterials 43:44–9.
   PubMed Web of Science ®Google Scholar
• Xie LX, Zhong W, Shi W, Sun S. (2006). Spectrum of fungal keratitis in north China. Ophthalmology 113:1943–8.
   PubMed Web of Science ®Google Scholar
• Zhang JX, Ma PX. (2013). Cyclodextrin-based supramolecular systems for drug delivery: recent progress and future perspective. Adv Drug Deliv Rev 65:1215–33.
   PubMed Web of Science ®Google Scholar